Twist Bioscience promotes Patrick Finn to President and COO

Twist Bioscience Corp

Patrick Finn, formerly Chief Commercial Officer, appointed President and COO effective October 25, 2022.
Finn joined Twist in 2015 and led sales growth from $2M (FY2016) to $184M (12 months ended June 30, 2022).
New role adds oversight of operations to commercial responsibilities.
Compensation: base salary $470,000, 60% bonus target, $100,000 one-time cash bonus, $10K/month housing allowance, and $4.4M in RSUs. equity award.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Patrick Finn

President and Chief Operating Officer

TWST · Twist Bioscience Corp

Effective: 2022-10-25
Filed: October 26, 2022, 7:59 PM ET

On October 25, 2022, the Board of Directors of Twist Bioscience Corporation (the “Company”) appointed Patrick Finn as President and Chief Operating Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Finn was appointed as President and Chief Operating Officer at Twist Bioscience Corp.

Action: appointed
Role: President and Chief Operating Officer

Exact text from the filing

On October 25, 2022, the Board of Directors of Twist Bioscience Corporation (the “Company”) appointed Patrick Finn as President and Chief Operating Officer of the Company, effective immediately.

View on SEC.gov

Twist Bioscience Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-111354

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.